Physician profile
Praneet Iyer
NPI 1023435609
$1,372.04
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.11 · 2020: $237 · 2021: $446 · 2022: $314 · 2023: $266 · 2024: $98.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $269.83 | 2020-2024 | Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $247.29 | 2019-2023 | Trelegy Ellipta |
| Mallinckrodt Hospital Products INC. | $151.75 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $101.98 | 2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $81.35 | 2021-2022 | |
| Edwards Lifesciences Corporation | $56.30 | 2020 | |
| La Jolla Pharmaceutical Company | $54.19 | 2021 | |
| Genentech USA, INC. | $51.18 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.82 | 2021-2022 | |
| Ambu INC. | $39.36 | 2022 | |
| Advanced Respiratory, INC | $34.20 | 2021 | |
| Pinnacle Biologics, INC | $27.53 | 2024 | Photofrin |
| Novartis Pharmaceuticals Corporation | $24.40 | 2021 | |
| Grifols USA, LLC | $22.22 | 2022 | |
| United Therapeutics Corporation | $19.61 | 2024 | Tyvaso |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $19.46 | 2022 | |
| Mylan Specialty L.P. | $19.17 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $17.65 | 2022 | |
| Abbvie INC. | $16.86 | 2021 | |
| Merck Sharp & Dohme LLC | $14.86 | 2020 | |
| Genzyme Corporation | $13.74 | 2022 | |
| Amgen INC. | $13.17 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.67 | 2021 | |
| Insmed, INC. | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praneet Iyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.